The good news: Drug shortages in 2023 have declined in the United States from their recent peak between 2010 and 2012. ...
Equipment4cpr
Delays in drug approval cost pharmaceutical companies money. These costs include both lost sales and the additional cost if clinical trials need to last ...
Recently, the Inflation Reduction Act (IRA) is receiving a lot of attention, particularly for its provision that allows CMS to begin price negotiations for ...
The above is the title of a useful manual of Kenney and Keast (2024). I summarize some key points below. Provide an overview of pharmacy contracts ...
Imagine facing the daily challenges of managing your chronic illness and then discovering that the medication vital to your well-being has a price out of your ...
For patients with serious illnesses, timely access to effective medications is paramount. The European Medicines Agency (EMA) was created in part to help ...
Prescription and over-the-counter drug ...
Author: Pavel Kuljuk Contact: Contact detailsPublished: 2024/02/28 - Updated: 2024/02/29Post type: Opinion Article / Editorial - Peer Reviewed: N/AContent: ...
That's the title of a recent article by Hernandez and Hung (2024). The article provides an excellent review of how ...
2023 was a good year for drug discovery. Mullard et al. (2024) report: The FDA's Center for Drug Evaluation and ...